MapLight Therapeutics, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingNewest
None
No S-3 or F-3 shelf on file in the last 30 months.
1 of its filings are not read yet.
Warrants
The 10-Q filed 2026-08-13 is not read yet.
Cash
7 quarters
$304.7M on 2026-06-30 ÷ $43.7M a quarter of operating cash used, the average of four quarters. 10-Q ↗
Raised: 4 of its filings are not read yet.